Swaziland, South Africa announce initiative to improve diagnosis, treatment of TB/HIV co-infection

NewsGuard 100/100 Score

"Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of [tuberculosis (TB)]/HIV in their countries," VOA News reports. "The initiative to bring about a more vigorous response to deal with TB/HIV and [multidrug-resistant tuberculosis (MDR-TB)] is being funded by the Global Fund [to Fight AIDS, Tuberculosis and Malaria], along with other partnerships, and the mining sector," the news service writes (Lewis, 3/20). "The initiative was unveiled at a press briefing in Johannesburg, South Africa on 20 March and will be formerly launched on 21 March in Mbabane, Swaziland," UNAIDS notes in an article on its webpage. "The initiative includes a package of new investments worth more than $120 million, which will be used to expedite progress against TB and HIV in the next 1000 days," the article states, adding, "The initiative will work with South African Development Community (SADC) countries to achieve the international targets of cutting deaths from TB and HIV-associated TB by half by 2015" (3/20).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Global HIV epidemic cannot be ended without keeping former prisoners, other patients engaged in care